Ways to handle the isolation that can come with the holidays

Enrollment hits 75% for Phase 2b clinical trial of Haduvio for IPF

Trevi Therapeutics announced that its ongoing Phase 2b clinical trial testing Haduvio (nalbuphine extended-release tablets) in people with idiopathic pulmonary fibrosis (IPF) who have chronic cough has reached 75% of its targeted patient enrollment. The Phase 2b CORAL trial (NCT05964335) is still seeking to recruit a…

Dealing with grief during a season of joy

Good grief! When I hear this two-word phrase, I often associate it with the cartoon character Charlie Brown. Otherwise, the words “good” and “grief” seldom seem to belong together. What do you do with grief amid the holiday season? If you’ve been reading my columns for some time,…

My tips for a safe holiday before and after transplant

Families will gather this week to celebrate Thanksgiving here in the U.S. But how do you safely navigate a large family gathering when colds, the flu, and COVID-19 are all circulating? When I was diagnosed with idiopathic pulmonary fibrosis (IPF) in 2017, a lot changed in my world.

Some helpful hacks for those living with IPF

Do you know what a hack is? It’s a way of doing something more simply, efficiently, or effectively. Throughout my journey living with idiopathic pulmonary fibrosis (IPF), I’ve found a number of hacks that make my life easier. When I was diagnosed with IPF in January 2017, I…

MNKD-201, inhaled nintedanib for IPF, found safe in healthy people

MNKD-201, Mannkind’s inhaled formulation of nintedanib for treating idiopathic pulmonary fibrosis (IPF), was found to be safe and well tolerated in a Phase 1 clinical trial involving healthy volunteers — meeting the study’s primary goal. The trial’s results also showed that participants did not experience the typical adverse…